Baker Bros. Advisors LP 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | Baker Bros. Advisors LP | 65,815,692 4.800% | 6,830,430 (+11.58%) | Filing |
| 2021-02-16 4:08 pm Purchase | 2020-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | Baker Bros. Advisors LP | 58,985,262 6.400% | 58,985,262 (New Position) | Filing |